#52026XC00402Avrupa Birliği'nin 1 Aralık 2025 ile 31 Aralık 2025 tarihleri arasında tıbbi ürünlere ilişkin pazarlama izinlerine dair kararların özeti (Avrupa Parlamentosu ve Konseyi'nin (EC) No 726/2004 veya Avrupa Parlamentosu ve Konseyi'nin (EU) 2019/6 sayılı Yönetmeliğinin 13. veya 38. Maddesi uyarınca yayımlanmıştır)
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
🇬🇧 English
This law outlines the European Union's decisions regarding the approval of medicinal products for marketing during the specified period. It affects pharmaceutical companies seeking to sell new medicines in the EU. The decisions are based on regulations that ensure safety and efficacy of these products.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- New marketing authorisations granted for specific medicinal products
- Updates to safety and efficacy requirements
- Streamlined application processes for pharmaceutical companies
Affected Parties
Pharmaceutical companiesHealthcare providers+1 more…
Tags
medicinal products,marketing authorisation,European Union…